Stockscreener 앱 받기
6.98
0.94%
0.065
시간 외 거래:
6.80
-0.18
-2.58%
Lifeward Ltd 주식(LFWD)의 최신 뉴스
Lifeward Ltd. (LFWD) Q1 2026 Earnings: Deep EPS Miss Tempered by Resilient Stock PerformanceProfit Warning Alert - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Amidst Unreported RevenueROIC Trend Report - newsline.com
Lifeward Ltd. (LFWD) Hovers Near Support as Minimal Downside Move Signals CautionLarge Cap Trends - newsline.com
Lifeward Ltd. (LFWD) Holds Steady Near Support Amid Quiet Trading SessionSector Leader Stocks - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Weighs on StockEPS Consistency Score - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Amid Challenging QuarterGuidance vs Actual - newsline.com
LFWD Technical Analysis | Trend, Signals & Chart Patterns | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
LFWD News | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
LFWD Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Revenue Not DisclosedEPS Revision Trend - newsline.com
Lifeward Q1 2026 Earnings: Significant EPS Miss Reflects Continued InvestmentEarnings Cycle Report - The Legal Advocate
LFWD Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Company Faces ChallengesMid-Term Outlook - newsline.com
Why Is Lifeward Ltd. (LFWD) Stock Down Today? - Meyka
Lifeward Ltd. (LFWD) Edges Higher as Support Holds, Resistance in FocusParabolic SAR - The Legal Advocate
Lifeward Ltd. (LFWD) Gains Ground: Testing Key Resistance at $7.48Death Cross - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Despite Stock RallyLow Growth Earnings - newsline.com
H.C. Wainwright Maintains Lifeward(LFWD.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Lifeward Ltd. (LFWD) Nears Key Support Amid Modest DeclineSupport Level Bounce - newsline.com
Lifeward Ltd. (LFWD) Surges Over 11% as Shares Test Key ResistanceVolatility Stop - The Legal Advocate
Lifeward (LFWD) Q4 2025 Earnings Transcript - AOL.com
Lifeward’s Earnings Call Balances Setbacks and Strategy - The Globe and Mail
Lifeward (Nasdaq: LFWD) posts wider Q1 loss, adds Oratech and new convertible debt - Stock Titan
Lifeward (LFWD) Chief Medical Officer receives 15,000-share RSU award - Stock Titan
Lifeward (LFWD) Chief Medical Officer discloses 2,083 ordinary shares - Stock Titan
Lifeward promotes Keith Rose to chief medical officer By Investing.com - Investing.com Nigeria
Lifeward Ltd. Appoints Keith D. Rose, M.D. as Chief Medical Officer – SEC 8-K Filing May 2026 - Minichart
Lifeward appoints Keith D. Rose, M.D. as chief medical officer By Investing.com - Investing.com Australia
Lifeward appoints Keith D. Rose, M.D. as chief medical officer - Investing.com
Lifeward Names Keith D. Rose as Chief Medical Officer - TipRanks
Lifeward (NASDAQ: LFWD) appoints Keith D. Rose, M.D. as new CMO - Stock Titan
Lifeward promotes Keith Rose to chief medical officer - Investing.com
Lifeward Appoints Dr. Keith D. Rose as Chief Medical - GlobeNewswire
Lifeward Ltd.16079622026 - SEC.gov
Lifeward (LFWD) price target decreased by 37.93% to 4.59 - MSN
How The Lifeward (LFWD) Story Is Shifting With New Price Targets And Valuation Assumptions - Yahoo Finance
Lifeward Ltd (LFWD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing Growth Opportunities - GuruFocus
Lifeward Earnings Call Balances Growth With Disruptions - The Globe and Mail
Number of shareholders of Lifeward Ltd. – BOATS:LFWD - TradingView
Lifeward Q1 earnings preview - MSN
Earnings Call Summary | Lifeward(LFWD.US) Q1 2026 Earnings Conference - 富途牛牛
Lifeward 1Q Loss/Shr $6.70 >LFWD - Moomoo
Lifeward Q1 2026 Loss Deepens: -$3.13/Share vs -$0.34 Expected - AlphaStreet
Lifeward Ltd (LFWD) Q1 2026 Earnings Miss: EPS -$6.70 vs -$1.26 - GuruFocus
Lifeward (LFWD) Q1 2026 Earnings Transcript - AOL.com
Lifeward expects 2026 revenue similar to 2025 following Oratech acquisition and $10M convertible note financing - MSN
Lifeward Ltd. Q1 2026 Earnings Call Summary - Yahoo Finance
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates - sharewise.com
Lifeward Ltd. Closes Oratech Acquisition, Receives $10M Financing, Launches Phase 2 Oral Insulin Trial, and Expands Exoskeleton Technology for Stroke Rehabilitation - Minichart
Transcript : Lifeward Ltd., Q1 2026 Earnings Call, May 15, 2026 - marketscreener.com
Lifeward Ltd (NASDAQ:LFWD) Q1 Revenue Misses Estimates as Strategic Transformation Takes Shape - ChartMill
Lifeward Delays Quarterly Report Amid Deal Accounting - TipRanks
2.43%
자본화:
|
볼륨(24시간):